环加氧酶和脂加氧酶双抑制剂1,3-二芳基prop-2-yn-1-ones的合成及构效关系研究。

文章的细节

引用

饶培宁,陈qh, Knaus EE

环加氧酶和脂加氧酶双抑制剂1,3-二芳基prop-2-yn-1-ones的合成及构效关系研究。

中华医学杂志,2006;49(5):1668-83。

PubMed ID
16509583 (PubMed视图
]
摘要

设计、合成了一组含有C-3 p-SO2Me COX-2药效团的1,3-二芳基prop-2- yn1 -ones(13,17,23,26和27),并评价了它们作为环氧化酶-1/2 (COX-1/2)和5/15-脂氧化酶(5/15-LOX)的潜在双重抑制剂,具有体内抗炎和镇痛活性。在这类化合物中,3-(4-甲磺酰基苯基)-1-(4-氟苯基)prop-2-yn-1-one (13h)被鉴定为一种有效的选择性COX-2抑制剂(COX-2 IC50 = 0.1微米;SI = 300),效力是罗非昔布的5倍(COX-2 IC50 = 0.5微米;[qh] [qh]在大鼠角叉菜胶诱导的足跖水肿实验中,在口服剂量为30mg /kg的角叉菜胶3小时后,13h表现出中度抗炎活性(26%的炎症抑制)。相关双COX-1/2和5/15-LOX抑制剂3-(4-甲磺酰基苯基)-1-(4-氰苯基)prop-2-yn-1-one (13g, COX-1 IC50 = 31.5微米;COX-2 IC50 = 1.0微米;Si = 31.5;5-LOX IC50 = 1.0微米;15-LOX IC50 = 3.2微米)表现出更强的抗炎活性(ED50 = 90 mg/kg),优于参比药阿司匹林(ED50 = 129 mg/kg)。 Within this group of compounds 3-(4-methanesulfonylphenyl)-1-(4-isopropylphenyl)prop-2-yn-1-one (13e) emerged as having an optimal combination of in vitro COX-1/2 and 5/15-LOX inhibitory effects (COX-1 IC50 = 9.2 microM; COX-2 IC50 = 0.32 microM; SI = 28; 5-LOX IC50 = 0.32 microM; 15-LOX IC50 = 0.36 microM) in conjunction with a good antiinflammatory activity (ED50 = 35 mg/kg) compared to the reference drug celecoxib (ED50 = 10.8 mg/kg) when administered orally. A molecular modeling study where 13e was docked in the COX-2 binding site indicated the C-1 p-i-Pr group was positioned within a hydrophobic pocket (Phe205, Val344, Val349, Phe381 and Leu534), and that this positioning of the i-Pr group facilitated orientation of the C-3 p-SO2Me COX-2 pharmacophore such that it inserted into the COX-2 secondary pocket (His90, Arg513, Ile517 and Val523). A related docking study of 13e in the 15-LOX binding site indicates that the C-3 p-SO2Me COX-2 pharmacophore was positioned in a region closer to the catalytic iron site where it undergoes a hydrogen bonding interaction with His541 and His366, and that the C-1 p-i-Pr substituent is buried deep in a hydrophobic pocket (Ile414, Ile418, Met419 and Ile593) near the base of the 15-LOX binding site.

引用这篇文章的药物银行数据

绑定属性
药物 目标 财产 测量 pH值 温度(°C)
乙酰水杨酸 前列腺素G/H合成酶2 IC 50 (nM) 2400 8 37 细节
塞来昔布 前列腺素G/H合成酶2 IC 50 (nM) 70 8 37 细节
前列腺素G/H合成酶2 IC 50 (nM) 500 8 37 细节